Viantis is a biotechnology company at the intersection of synthetic biology and artificial intelligence, pioneering a new class of DNA-based medical devices designed to block viral infections at their point of entry. Our first focus is on Human Papillomavirus (HPV), the leading cause of cervical cancer and one of the most widespread sexually transmitted infections worldwide.